Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2024-03-22 00:00:00 ET · period of report 2024-03-21 · accession 0001492613-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-22 | 2024-03-21 | AIM | BRYAN NANCY | Dir | P - Purchase | $0.39 | +38.5K | 38.5K | New | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-21 | P | A | 38,462 | $0.39 | 38,462 | D | — | — |